Why is the US Pharma & Biotech Neuroscience June 2026 Report useful and how should I use it?

Why is the US Pharma & Biotech Neuroscience June 2026 Report useful? Imagine being able to instantly see your competitors Market Share, Share of Spend and their top performing ad copy so you can effectively benchmark your own performance. Adthena’s PPC Market Share reports provide an instant view of performance insights across hundreds of sub-industries – so you can do just that. How to use the US Pharma & Biotech Neuroscience June 2026 Report Think of these reports as a cheat sheet for your industry’s search landscape. Check out this short article for a breakdown of each report and how they can benefit your strategy.

How often is the data updated?

Data within the US Pharma & Biotech Neuroscience June 2026 Report is aggregated every month, highlighting the most significant changes from the previous period.

How does Adthena collect this data?

We use observed data from Google’s search results pages. With 20 million Google SERPs indexed per day. Adthena forms a global index of publicly available searches on Google. On top of observed data, our data science models and patented technology expand on the insights through estimated metrics like market share, share of spend, and more. We have 12 years of historical data across industries and our custom-built AI models learn from continuously updated data every day.

How accurate is the US Pharma & Biotech Neuroscience June 2026 Report?

The US Pharma & Biotech Neuroscience June 2026 Report is powered by Adthena’s Whole Market View, which is the patented technology that drives value for our 300 enterprise customers. Our unique approach to search intelligence ingests Google’s Keyword Planner into its learning models, providing a more accurate and up-to-date view of keyword data compared to traditional panel data methods. With daily data collection and updates, Adthena offers a closer-to-real-time view of the Google Ads auction, enabling timely insights and adjustments. Adthena focuses specifically on Google Ads, providing a deep dive into the channel and offering detailed insights into its workings. By processing 10 TB of new data daily and employing AI and machine learning models to analyze millions of Google Ads searches per second, Adthena provides a comprehensive and in-depth view of the competitive landscape. Learn more about our data. Learn more about our data accuracy

Does this include mobile, desktop and Google Shopping data?

Yes. The US Pharma & Biotech Neuroscience June 2026 Report aggregates data from across both device types and Google Shopping.

Who is this US Pharma & Biotech Neuroscience June 2026 Report for?

The US Pharma & Biotech Neuroscience June 2026 Report is for enterprise brands and agencies who want quick and high-level, historical benchmarks that are easily digestible and reveal insights, trends and market winners relevant to their own industry.

Ask Arlo leverages real-time GenAI to answer customers’ questions about their own search data and receive instant, tailored responses and reports directly within the Adthena platform. With millions of Google SERPs indexed every day, Arlo never misses a trick and makes sure you’re always up to date. Learn more about Ask Arlo.

US Pharma & Biotech Neuroscience - PPC Market Share Analysis June 2026

Leveraging Adthena’s Whole Market View, this analysis explores recent trends in Google Ads for the US Neuroscience category from the last month. Our Data Analyst, Ask Arlo provides commentary on key findings.

Google AI Overview visibility for Pharma & Biotech Neuroscience US

See how often AIOs appear and how search intent is distributed across buying signals.

See more data

AIO Frequency

How often a Google AI overview appears on search terms relevant to this category.

Frequency	Percentage
Frequency	67.2889397516
	32.7110602484

67%

Complex Query Frequency

A complex query is a longer, more detailed search that often contains multiple keywords, specific conditions, or multi-part questions.

Frequency	Percentage
Frequency	35
	65

35%

Search Intent Distribution

Breakdown of search queries by their underlying goal.

Intent	Distribution
Investigational	8%
Transactional	3%
Navigational	0%
Seasonal	0%
Local	0%
Problem Solving	36%

Market Exposure

Share of Clicks for top 10 US Pharma & Biotech Neuroscience brands

Here are the Top 10 competitors in the industry by Share of Clicks for the last month.

See more data

Share of Clicks - Last month

Share of Clicks - Last month
Domain	Share of clicks
vraylar.com	30.63
rexulti.com	21.69
vraylarhcp.com	11.19
caplyta.com	6.71
rexultihcp.com	5.63
nurtec.com	4.49
vyepti.com	3.77
fanapt.com	2.28
zavzpret.com	0.7
kesimptahcp.com	0.65
others	12.26

vraylar.com - 30.63%
rexulti.com - 21.69%
vraylarhcp.com - 11.19%
caplyta.com - 6.71%
rexultihcp.com - 5.63%
nurtec.com - 4.49%
vyepti.com - 3.77%
fanapt.com - 2.28%
zavzpret.com - 0.7%
kesimptahcp.com - 0.65%
others - 12.26%

In the competitive landscape of Google PPC, vraylar.com leads with 30.63% click share, followed by rexulti.com at 21.69%. ‘Others’ collectively hold 12.26%, showcasing diverse competition.

Market Exposure

Share of Spend for the top 10 US Pharma & Biotech Neuroscience brands

Curious about your market position? Here you can see the Top 10 competitors in the industry by Share of Spend for the last month.

See more data

Share of Spend - Last Month

Share of Spend - Last Month
Date	vraylar.com	rexulti.com	vraylarhcp.com	rexultihcp.com	vyepti.com	nurtec.com	kesimptahcp.com	caplyta.com	fanapt.com	parkinson.org
2026/06/01	31.99%	19.29%	9.76%	6.81%	3.59%	2.95%	0.51%	8.38%	1.45%	0.29%
2026/06/02	34.49%	13.4%	10.25%	6.14%	4.17%	4.92%	0.58%	9.1%	1.78%	0.77%
2026/06/03	34.78%	15.63%	10.16%	4.97%	3.03%	5.92%	0.33%	13.13%	0.7%	0.03%
2026/06/04	36.92%	13.84%	15.44%	6.38%	4.02%	3.46%	0.99%	2.03%	1.53%	0.6%
2026/06/05	36.5%	14.9%	12.83%	6.16%	4.93%	2.53%	0.52%	5.49%	1.43%	0.04%
2026/06/06	36.99%	14.97%	10.91%	5.54%	3.41%	2.74%	0.54%	9.68%	1.61%	1.53%
2026/06/07	32.94%	15.21%	12.06%	5.7%	3.49%	1.8%	0.67%	10.39%	1.11%	2.62%
2026/06/08	36.52%	8.65%	13.35%	3.88%	5.14%	3.16%	0.53%	11.75%	1.07%	0.58%
2026/06/09	26.39%	16.49%	12.59%	6.85%	5.43%	4.53%	1.31%	8.21%	1.39%	1.31%
2026/06/10	31.84%	17.26%	9.07%	7.66%	5.27%	6.36%	1.18%	4.54%	1.1%	0.07%
2026/06/11	36.75%	12.74%	16.11%	4.15%	3.49%	3.56%	1.01%	8.55%	1.48%	0.02%
2026/06/12	42.2%	10.81%	17.59%	4.5%	2.71%	3.2%	0.8%	6.28%	1.41%	0.54%
2026/06/13	38.17%	12.64%	13.36%	3.83%	3.03%	3.61%	0.82%	8.34%	0.65%	1.2%
2026/06/14	41.06%	13.49%	16.02%	4.4%	1.7%	3.35%	0.87%	2.3%	1.18%	0.66%
2026/06/15	42.88%	13.96%	15.86%	4.19%	2.88%	4.24%	0.31%	5.61%	1.28%	0%
2026/06/16	37.03%	15.58%	11.11%	6.08%	3.94%	5.83%	0.59%	6.58%	1%	0.63%
2026/06/17	36.99%	13.25%	15.19%	4.1%	2.18%	3.05%	0.38%	10.44%	0.74%	0.04%
2026/06/18	35.27%	18.52%	9.33%	7.21%	2.11%	4.12%	0.88%	7.02%	1.06%	1.03%
2026/06/19	36.72%	16.18%	14.48%	6.31%	2.79%	5.25%	0.18%	7.43%	0.59%	0.6%
2026/06/20	31.11%	14.55%	11.07%	6.19%	3.12%	5.43%	0.36%	13.85%	0.81%	1.08%
2026/06/21	31.93%	14.83%	11.51%	7.08%	2.03%	4.73%	0.46%	13.26%	0.55%	2.31%
2026/06/22	29.44%	16.16%	11.58%	6.8%	3.28%	5.22%	0.39%	15.82%	0.57%	1.08%
2026/06/23	34.89%	17.18%	13.08%	6.41%	2.69%	2.86%	0.68%	11.12%	0.94%	0%
2026/06/24	32.42%	17.18%	12.8%	5.9%	4.08%	2.78%	1.01%	13.56%	0.68%	1.05%
2026/06/25	29.42%	16.93%	9.17%	6.35%	4.67%	3.11%	1.44%	13.61%	0.62%	0.61%
2026/06/26	27.59%	23.35%	10.79%	8.57%	6.03%	3.02%	0.8%	7.28%	1.06%	1.36%
2026/06/27	33.99%	18.79%	11.97%	11.24%	4.88%	1.77%	0.8%	3.97%	0.87%	1.37%
2026/06/28	42.4%	16.78%	14.12%	6.11%	5.25%	2.13%	0.69%	1.58%	1.08%	0.05%
2026/06/29	36.46%	19.41%	13.71%	7.64%	3.78%	1.72%	1.37%	2.03%	0.78%	0.56%
2026/06/30	35.41%	19.15%	10.97%	6.44%	5.71%	2.46%	1.67%	1.15%	0.4%	0.01%

vraylar.com
rexulti.com
vraylarhcp.com
rexultihcp.com
vyepti.com
nurtec.com
kesimptahcp.com
caplyta.com
fanapt.com
parkinson.org

Vraylar.com led June with a peak at 42.88% on the 15th. Rexulti.com saw a steady rise, closing at 19.15%. Vraylarhcp.com fluctuated, peaking mid-month. Caplyta.com surged mid-June, then declined.

Market Exposure

Competitor Count for US Pharma & Biotech Neuroscience

Ever wondered how many competitors you’re up against in your industry? Well look no further, here we can see the number of advertisers bidding over the last month.

See more data

Competitor Count - Last month

Competitor Count - Last month
Date	Competitor Count
2026/06/01	89
2026/06/02	91
2026/06/03	88
2026/06/04	89
2026/06/05	91
2026/06/06	87
2026/06/07	95
2026/06/08	94
2026/06/09	93
2026/06/10	86
2026/06/11	95
2026/06/12	85
2026/06/13	93
2026/06/14	91
2026/06/15	88
2026/06/16	86
2026/06/17	87
2026/06/18	88
2026/06/19	80
2026/06/20	81
2026/06/21	81
2026/06/22	85
2026/06/23	81
2026/06/24	80
2026/06/25	78
2026/06/26	76
2026/06/27	78
2026/06/28	76
2026/06/29	84
2026/06/30	81

In June 2026, distinct advertisers fluctuated, peaking at 95 on June 7 and 11. A decline followed, ending at 81 on June 30.

Campaign Efficiency

Market Loss & Market Gains for US Pharma & Biotech Neuroscience

Here we’re looking at the Top 10 biggest industry movers by market share gains and losses for the last 30 days.

See more data

Market Loss & Market Gains - Last month

Market Loss & Market Gains - Last month
Name	Market Trend
rexulti.com	4.41%
rexultihcp.com	1.25%
caplyta.com	1.06%
injectionsforschizophrenia.com	0.41%
michaeljfox.org	0.22%
parkinsonfoundation.org	-0.38%
nurtec.com	-0.44%
fanapt.com	-0.74%
vraylarhcp.com	-1.06%
vraylar.com	-2.95%

Rexulti.com surged with a 4.41% click share increase, while vraylar.com dropped by 2.95%. Caplyta.com and rexultihcp.com also gained, contrasting with declines for vraylarhcp.com and fanapt.com.

Campaign Efficiency

US Pharma & Biotech Neuroscience Share of Impressions

Take a look at the Top 10 competitors in the industry by Share of Impressions over the last month.

See more data

Date	vraylar.com	vraylarhcp.com	vyepti.com	rexulti.com	rexultihcp.com	nurtec.com	caplyta.com	abilifyasimtufii.com	zavzpret.com	fanapt.com
2026/06/01	17.09%	11.48%	7.26%	13.89%	10.99%	3.8%	6.12%	0.6%	2.53%	2.39%
2026/06/02	18.33%	11.55%	8.16%	9.6%	9.85%	7.19%	5.21%	1.65%	1.94%	2.93%
2026/06/03	20.49%	13.57%	6.92%	11.06%	9.6%	9.78%	7.19%	0.41%	0.74%	1.13%
2026/06/04	19.29%	17.97%	8.09%	9.13%	9.83%	4.58%	1.56%	1.76%	2.11%	2.32%
2026/06/05	19.42%	16.23%	10.13%	8.66%	10.99%	3.26%	3.47%	1.2%	1.44%	2.29%
2026/06/06	20.64%	13.41%	7.17%	9.77%	10.18%	4.13%	8.22%	2.51%	1.07%	2.5%
2026/06/07	18.5%	14.31%	7.23%	10.41%	10.48%	2.25%	7.12%	1.76%	1.88%	1.82%
2026/06/08	19.78%	15.92%	11.2%	5.91%	6.56%	4.51%	6.72%	1.57%	2.85%	1.53%
2026/06/09	13.62%	12.5%	11.42%	10.72%	11.25%	6.56%	4.92%	1.49%	1.64%	2.29%
2026/06/10	16.37%	11.39%	10.32%	9.2%	12.05%	8.85%	4.03%	2.95%	3.1%	1.45%
2026/06/11	19.94%	19.34%	7.39%	7.84%	8.4%	5.01%	5.66%	3.89%	1.41%	2.54%
2026/06/12	24.48%	21.25%	6.11%	7.08%	9.05%	4.91%	4.22%	1.09%	1.34%	2.31%
2026/06/13	22.23%	17.12%	6.88%	7.73%	7.18%	5.42%	5.54%	0.67%	1.1%	0.99%
2026/06/14	23.37%	19.4%	3.9%	8.43%	8.17%	4.85%	2.12%	2.19%	0.78%	1.95%
2026/06/15	25.32%	20.87%	6.14%	8.98%	7.89%	6.5%	5.43%	1.06%	0.36%	1.9%
2026/06/16	20.73%	14.09%	8.37%	10.15%	10.18%	9.07%	3.97%	0.79%	1.15%	1.54%
2026/06/17	21.93%	20.07%	4.77%	8.65%	7.73%	4.78%	6.06%	0.17%	0.84%	1.09%
2026/06/18	18.75%	12.57%	4.5%	12.8%	11.42%	5.98%	7.14%	0.29%	0.94%	1.49%
2026/06/19	21.19%	18.86%	6.27%	10.5%	11.53%	8.3%	4.74%	1.76%	0.4%	0.79%
2026/06/20	17.7%	13.94%	6.68%	9.45%	11.46%	8.8%	8.98%	1.27%	1.62%	1.16%
2026/06/21	19.03%	14.31%	4.85%	10.6%	12.47%	7.71%	8.31%	1.81%	0.66%	0.84%
2026/06/22	16.82%	15.03%	7.34%	10.86%	11.61%	8.59%	9.5%	1.69%	1.53%	1.03%
2026/06/23	20.57%	17.33%	6.25%	12.02%	11.84%	4.12%	6.86%	0.89%	1.99%	1.63%
2026/06/24	19.39%	17.63%	9.48%	11.16%	11.21%	4.35%	8.86%	0.61%	1.62%	1.12%
2026/06/25	16.19%	11.32%	10.29%	10.61%	11.71%	4.42%	9.07%	1.96%	1.29%	0.87%
2026/06/26	14.6%	13.65%	12.86%	13.31%	13.66%	4.11%	6.24%	1.38%	3.84%	1.44%
2026/06/27	18.59%	14.87%	10.55%	14.26%	16.64%	2.1%	4.04%	0.66%	2.34%	1.16%
2026/06/28	23.91%	18.89%	11.5%	10.82%	10.72%	2.51%	2.74%	2.77%	1.09%	1.55%
2026/06/29	20.02%	15.97%	8%	13.02%	13.85%	1.98%	2.52%	1.78%	0.5%	1.29%
2026/06/30	18.22%	13.24%	11.97%	11.9%	10.79%	2.93%	1.91%	1.44%	0.97%	0.69%

vraylar.com
vraylarhcp.com
vyepti.com
rexulti.com
rexultihcp.com
nurtec.com
caplyta.com
abilifyasimtufii.com
zavzpret.com
fanapt.com

In June 2026, vraylar.com led with fluctuating impressions, peaking mid-month at 25.32%. Vraylarhcp.com followed, showing a steady rise, while vyepti.com and rexulti.com had moderate gains. Caplyta.com and nurtec.com saw declines, ending the month lower.

Campaign Efficiency

Google Text Ad Copy Insights & Creative Trends for US Pharma & Biotech Neuroscience

Ever wondered how your rivals’ ads are doing? Here we can see the top-performing ads in the industry over the last month.

See more data

Google Text Ad Copy Insights & Creative Trends for US Pharma & Biotech Neuroscience - Last month

1
CAPLYTA® (lumateperone) - Official Patient Website https://www.caplyta.com/
Visit the Official Site for Product & Safety Information, Including Boxed WARNINGS. Find Out Information On CAPLYTA® & How To Talk To...
2
REXULTI® (brexpiprazole) - Information For Patients https://www.rexulti.com/
REXULTI® (brexpiprazole) Important Safety, Prescribing Info & Boxed Warning.
3
REXULTI® (brexpiprazole) - Healthcare Professional Site https://www.rexultihcp.com/
REXULTI® (brexpiprazole) Important Safety, Prescribing Info & BOXED WARNING. View REXULTI® Safety & Prescribing Info, & BOXED WARNING.
4
VRAYLAR® (cariprazine) - Medication Information https://www.vraylar.com/
See VRAYLAR® (cariprazine) Full Prescribing Information, Including Boxed Warnings.
5
VRAYLAR® (cariprazine) http://www.vraylarhcp.com
FDA-Approved Treatment — View Safety, Prescribing Info, and Boxed Warnings. Get More Information. Learn About VRAYLAR® and See if It's The Right Treatment for Your Patients.

In the competitive landscape of pharmaceuticals, CAPLYTA®, REXULTI®, and VRAYLAR® dominate Google’s PPC with a focus on safety and prescribing information. Their ads emphasize official sites, boxed warnings, and patient education, highlighting a commitment to informed healthcare decisions.

Frequently Asked Questions

Why is the US Pharma & Biotech Neuroscience June 2026 Report useful and how should I use it?

Why is the US Pharma & Biotech Neuroscience June 2026 Report useful?

Imagine being able to instantly see your competitors Market Share, Share of Spend and their top performing ad copy so you can effectively benchmark your own performance.

Adthena’s PPC Market Share reports provide an instant view of performance insights across hundreds of sub-industries – so you can do just that.

How to use the US Pharma & Biotech Neuroscience June 2026 Report
Think of these reports as a cheat sheet for your industry’s search landscape. Check out this short article for a breakdown of each report and how they can benefit your strategy.
How often is the data updated?

Data within the US Pharma & Biotech Neuroscience June 2026 Report is aggregated every month, highlighting the most significant changes from the previous period.
How does Adthena collect this data?

We use observed data from Google’s search results pages. With 20 million Google SERPs indexed per day. Adthena forms a global index of publicly available searches on Google.

On top of observed data, our data science models and patented technology expand on the insights through estimated metrics like market share, share of spend, and more.

We have 12 years of historical data across industries and our custom-built AI models learn from continuously updated data every day.
How accurate is the US Pharma & Biotech Neuroscience June 2026 Report?

The US Pharma & Biotech Neuroscience June 2026 Report is powered by Adthena’s Whole Market View, which is the patented technology that drives value for our 300 enterprise customers.

Our unique approach to search intelligence ingests Google’s Keyword Planner into its learning models, providing a more accurate and up-to-date view of keyword data compared to traditional panel data methods.

With daily data collection and updates, Adthena offers a closer-to-real-time view of the Google Ads auction, enabling timely insights and adjustments.

Adthena focuses specifically on Google Ads, providing a deep dive into the channel and offering detailed insights into its workings. By processing 10 TB of new data daily and employing AI and machine learning models to analyze millions of Google Ads searches per second, Adthena provides a comprehensive and in-depth view of the competitive landscape.

Learn more about our data.

Learn more about our data accuracy
Does this include mobile, desktop and Google Shopping data?

Yes. The US Pharma & Biotech Neuroscience June 2026 Report aggregates data from across both device types and Google Shopping.
Who is this US Pharma & Biotech Neuroscience June 2026 Report for?

The US Pharma & Biotech Neuroscience June 2026 Report is for enterprise brands and agencies who want quick and high-level, historical benchmarks that are easily digestible and reveal insights, trends and market winners relevant to their own industry.
Can I get a custom report for my brand?

Our search consultants can introduce you to data that is specific to your organization, based on the size of the relevant search term and competitor universe, and the geographies that need monitoring.

Complete the form below to get started.
What is Ask Arlo?

Ask Arlo leverages real-time GenAI to answer customers’ questions about their own search data and receive instant, tailored responses and reports directly within the Adthena platform.

With millions of Google SERPs indexed every day, Arlo never misses a trick and makes sure you’re always up to date.

Learn more about Ask Arlo.

Customer Success Stories

the7stars achieves Google Ads PPC campaign optimization with Adthena

Leveraging Adthena's comprehensive insights, the7stars and their lottery client optimized their PPC campaigns and organic strategies, resulting in substantial cost savings and improved campaign performance. Read case study

Sage case study: 75% decrease in CPCs with Adthena

Sage, a leading UK software provider, used Adthena’s brand protection strategy to curb rising CPC costs. By identifying brand infringements and optimizing spend, they effectively strengthened their brand protection strategy and increased ROI.Read case study

Vodafone case study: Driving click share and sales with strategic insights from Adthena

Vodafone used Adthena data to optimize results from the launch of the Samsung S22 product. Combining Adthena’s Strategic Insights with Google Smart Bidding, Vodafone was able to maintain a flexible strategy that leveraged both manual and automated bidding. Leveraging Adthena’s Search Term Opportunities report also allowed Vodafone to implement 27 keyword terms across their business line, driving an increase in revenue at a positive ROAS.Read case study

Get the full picture

See this data specific to your brand performance

The data on this page is just a sample of the billions of data points we hold at Adthena. The insights generated by Ask Arlo, leverage real-time GenAI to answer questions about your search data.

Our search consultants can introduce you to Whole Market View data that is specific to your organization, based on the size of the relevant search term and competitor universe, and the locations that you need monitoring.

US Pharma & Biotech Neuroscience - PPC Market Share Analysis June 2026

Neuroscience – US

Google AI Overview visibility for Pharma & Biotech Neuroscience US

AIO Frequency

Complex Query Frequency

Search Intent Distribution

Share of Clicks for top 10 US Pharma & Biotech Neuroscience brands

Share of Spend for the top 10 US Pharma & Biotech Neuroscience brands

Competitor Count for US Pharma & Biotech Neuroscience

Market Loss & Market Gains for US Pharma & Biotech Neuroscience

US Pharma & Biotech Neuroscience Share of Impressions

Google Text Ad Copy Insights & Creative Trends for US Pharma & Biotech Neuroscience

Frequently Asked Questions

Why is the US Pharma & Biotech Neuroscience June 2026 Report useful and how should I use it?

Why is the US Pharma & Biotech Neuroscience June 2026 Report useful?

How often is the data updated?

How does Adthena collect this data?

How accurate is the US Pharma & Biotech Neuroscience June 2026 Report?

Does this include mobile, desktop and Google Shopping data?

Who is this US Pharma & Biotech Neuroscience June 2026 Report for?

Can I get a custom report for my brand?

What is Ask Arlo?

Customer Success Stories

the7stars achieves Google Ads PPC campaign optimization​ with Adthena

Sage case study: 75% decrease in CPCs with Adthena

Vodafone case study: Driving click share and sales with strategic insights from Adthena

Get the full picture

See this data specific to your brand performance

the7stars achieves Google Ads PPC campaign optimization with Adthena